Idera Pharmaceuticals, Inc. (IDRA) To Present At The Nucleic Acid Summit 2014
6/16/2014 8:58:38 AM
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing novel nucleic acid therapeutics for orphan diseases, today announced that Walter Strapps, Ph.D., Executive Director of RNA Therapeutics, will present at the Nucleic Acid Summit 2014 in San Diego, California on Thursday, June 19, 2014 at 4:15 p.m. PDT. The title of Dr. Strapps’ presentation is "Gene Silencing Oligos: The Next Generation in Gene Silencing."
Help employers find you! Check out all the jobs and post your resume.